Back
Karuna Therapeutics Stock Price Chart
Early Profit-Advantage on 40-cent Stock as Uranium Bulls Take Over
More Here...
Buy
60
KRTX
Karuna Therapeutics
Last Price:
188.34
Seasonality Move:
1.93%
7 Day Trial
ALL ACCESS PASS
$
7
#1 Low-Priced Lithium Stock as Global EV Sales Accelerate
Find out more here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Karuna Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 183.55 | Buy |
| 20-day SMA: | 177.5 | Buy |
| 50-day SMA: | 172.89 | Buy |
| 200-day SMA: | 193.24 | Sell |
| 8-day EMA: | 184.39 | Buy |
| 20-day EMA: | 179.15 | Buy |
| 50-day EMA: | 177.31 | Buy |
| 200-day EMA: | 187.3 | Sell |
Karuna Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.17 | Buy |
| Relative Strength Index (14 RSI): | 56.98 | Buy |
| Chaikin Money Flow: | -72786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.84 - 183.58) | Buy |
| Bollinger Bands (100): | (167.93 - 194.19) | Buy |
Karuna Therapeutics Technical Analysis
| Nov 14 | Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karuna Therapeutics Stock
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 185.35 while KRTX 8-day simple moving average is 183.55, which is a Buy signal.
- The stock price of KRTX is 185.35 while Karuna Therapeutics 20-day SMA is 177.50, which makes it a Buy.
- Karuna Therapeutics 50-day simple moving average is 172.89 while KRTX share price is 185.35, making it a Buy technically.
- KRTX stock price is 185.35 and Karuna Therapeutics 200-day simple moving average is 193.24, creating a Sell signal.
KRTX Technical Analysis vs Fundamental Analysis
Buy
60
Karuna Therapeutics (KRTX)
is a Buy
Is Karuna Therapeutics a Buy or a Sell?
-
Karuna Therapeutics stock is rated a Buy
The current Karuna Therapeutics [KRTX] share price is $185.35. The Score for KRTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Karuna Therapeutics Stock Info
Market Cap:
6.99B
Price in USD:
185.35
Share Volume:
106.14K
Karuna Therapeutics 52-Week Range
52-Week High:
245.00
52-Week Low:
158.38
Buy
60
Karuna Therapeutics (KRTX)
is a Buy
Karuna Therapeutics Share Price Forecast
-
What is the Karuna Therapeutics stock price today?
The Karuna Therapeutics stock price is 185.35 USD today. -
Will KRTX stock go up or go down?
Karuna Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karuna Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karuna Therapeutics is not overvalued.
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 185.35 while KRTX 8-day exponential moving average is 184.39, which is a Buy signal.
- The stock price of KRTX is 185.35 while Karuna Therapeutics 20-day EMA is 179.15, which makes it a Buy.
- Karuna Therapeutics 50-day exponential moving average is 177.31 while KRTX share price is 185.35, making it a Buy technically.
- KRTX stock price is 185.35 and Karuna Therapeutics 200-day simple moving average is 187.30, creating a Sell signal.
Fundamental Analysis of Karuna Therapeutics
Is Karuna Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.18 per share, and an increase next year of $0.14 per share.
Technical Analysis of Karuna Therapeutics
Should I short Karuna Therapeutics stock?
- KRTX Moving Average Covergence Divergence (MACD) indicator is 4.17, suggesting Karuna Therapeutics is a Buy
- Karuna Therapeutics Relative Strength Index (RSI) is 56.98, which suggest Karuna Therapeutics is overbought
- The Bollinger Bands (25) for Karuna Therapeutics is (166.84 - 183.58), which suggest Karuna Therapeutics is a Buy
- The Bollinger Bands (100) for Karuna Therapeutics is (167.93 - 194.19), which suggest Karuna Therapeutics is a Buy
* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.